Posted on December 02, 2019

Dr. Mitchell Croatt (Chemistry & Biochemistry) received new funding from the National Institutes of Health National Cancer Institute for the project “TAK1 Inhibition by (5Z)-7-Oxozeaenol Analogues for Anticancer Leads.”

This project will develop new anticancer drug leads based on the natural product pharmacophore.

Latest News

April 6, 2026

UNCG Welcomes Bestselling Author Casey McQuiston to Greensboro Bound

UNCG will bring two of Greensboro Bound’s most anticipated authors to audiences for the 2026 book festival: Casey McQuiston and Im...

April 3, 2026

Gilman Scholars Gain Access to the World 

With 278 Gilman International Scholarship Program recipients — the most of any NC university — UNCG is opening doors to the worl...

April 2, 2026

Early Lessons for Students on the Path to Educating

School of Education students build upon their personal experiences to help other children thrive at school, and they know their Amer...

What's Trending

Connect with Us

Subscribe to our Top 5

Subscribe today to our Top 5 Weekly email

This field is for validation purposes and should be left unchanged.

Share Your Story

For the Media

Share This